MCL: mantle cell lymphoma; CR: complete response; HCT: hematopoietic cell transplantation; HiDAc: high-dose cytarabine; PET: positron emission tomography.
* The preferred induction regimen varies among experts; rituximab-bendamustine and options for a more intensive, HiDAc-containing regimen are discussed in a related UpToDate topic.
¶ Restaging according to Lugano criteria.
Δ Some experts proceed to maintenance therapy after HCT without repeating PET.آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟